Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels-Reference-Cited by-同舟云学术

Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels

Published:2015-08-11 Issue:6 Volume:314 Page:570
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Basaria Shehzad¹,Harman S. Mitchell²,Travison Thomas G.³,Hodis Howard⁴,Tsitouras Panayiotis⁵,Budoff Matthew⁶,Pencina Karol M.¹,Vita Joseph⁷,Dzekov Connie⁸,Mazer Norman A.⁹,Coviello Andrea D.¹⁰,Knapp Philip E.¹⁰,Hally Kathleen¹,Pinjic Emma¹,Yan Mingzhu⁴,Storer Thomas W.¹,Bhasin Shalender¹

Affiliation:

1. Research Program in Men’s Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Kronos Longevity Research Institute, Phoenix, Arizona3Phoenix VA Health Care System, Phoenix, Arizona

3. Research Program in Men’s Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts11Institute for Aging Research, Hebrew SeniorLife, Boston, Mass

4. Atherosclerosis Research Unit, Keck School of Medicine, University of Southern California, Los Angeles

5. Kronos Longevity Research Institute, Phoenix, Arizona5DWR Department of Geriatric Medicine, University of Oklahoma, Oklahoma City

6. Los Angeles Biomedical Research Institute, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California

7. Division of Cardiology, Boston University School of Medicine, Boston, Massachusetts

8. Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California

9. Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland10Division of Endocrinology, Boston University School of Medicine, Boston, Massachusetts

10. Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and testosterone therapy in male hypogonadism;Annals of the New York Academy of Sciences;2024-09-07

2. The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation;Health Technology Assessment;2024-08

3. Male hypogonadism: pathogenesis, diagnosis, and management;The Lancet Diabetes & Endocrinology;2024-08

4. Testosterone replacement therapy for hypogonadism;The Nurse Practitioner;2024-07-25

5. Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials;Annals of the New York Academy of Sciences;2024-07-22